Detail
| LncRNA Name | H19 |
| Synonyms | H19, ASM, ASM1, BWS, D11S813E, LINC00008, NCRNA00008, WT2 |
| Region | GRCh38_11:1995176-2001470 Sequence |
| Ensembl | ENSG00000130600 |
| RefSeq | NR_002196 |
| Circulating | ✘ |
| Drug-resisitant | ✘ |
| Prognostic | ✘ |
| MiRNA | ✘ |
| Variant | ✘ |
| TF | ✘ |
| Methylation | ✘ |
| Cancer Name | bladder cancer |
| ICD-0-3 | C67 |
| Methods | qPCR, RNAi, Western blot etc. |
| Sample | cell line (HTB-9, J82), bladder cancer tissues |
| Expression Pattern | up-regulated |
| Function Description | Up-regulation of H19 in bladder cancer tissues is correlated with clinical stage or metastasis of cancer.By cell transfection to suppress H19 expression in bladder cancer cells,E-cadherin expression is upregulated,thus weakening metastatic potency of cancer cells. |
| Pubmed ID | 29614625 |
| Year | 2018 |
| Title | Inhibition of E-cadherin expression by lnc-RNA H19 to facilitate bladder cancer metastasis. |
| External Links |
| Links for H19 | GenBank HGNC lncrnadb Noncode |
| Links for bladder cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.